FindTrial
Sign In

Contemporary outcomes and mortality risks of Ebstein anomaly

Contemporary outcomes and mortality risks of Ebstein anomaly

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
TCTR
Registry ID
TCTR20190124005
Enrollment
Unknown
Registered
2019-01-24
Start date
2017-06-23
Completion date
Unknown
Last updated
2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Ebstein anomaly (EA) is a complex congenital heart disease characterized by the delamination and downward displacement of tricuspid valve (TV) leaflets into the right ventricle (RV).1 A wide array of Ebstein anomaly&#44

Interventions

all patients who were diagnosed with EA by 2D&#45
tranthoracic echocardiography (2D&#45
TTE) between January 1&#44
1994 and December 31&#44
2016 in Siriraj Hospital&#44
Mahidol University
Other
Patients with Ebstein anomaly

Sponsors

Faculty of Medicine Siriraj hospital
Lead Sponsor
Faculty of Medicine Siriraj hospital
Collaborator

Eligibility

Sex/Gender
All
Age
0 Years to 80 Years

Inclusion criteria

Inclusion criteria: all patients who were diagnosed with EA by 2D-tranthoracic echocardiography (2D-TTE) between January 1, 1994 and December 31, 2016 in Siriraj Hospital, Mahidol University

Exclusion criteria

Exclusion criteria: patients with complex anomaly with Ebsteinoid valve i.e. corrected transposition of great arteries and patients who had undergone operation from other hospital were excluded.

Design outcomes

Primary

MeasureTime frame
Survival of patients with Ebstein anomaly End of 2017/ recent follow up/ death Survival—

Secondary

MeasureTime frame
Prognotic factors End of 2017/ recent follow up/ death Multivariate—

Contacts

Public ContactChodchanok Vijarnsorn

Faculty of Medicine Siriraj hospital

cvijarnsorn@yahoo.com+66 81 3447015

Outcome results

None listed

Source: TCTR (via WHO ICTRP) · Data processed: Aug 9, 2026